Is a prescription from another EU country valid in a Maltese pharmacy?

What EU law says about a prescription issued in another Member State

Directive 2011/24/EU on the application of patients' rights in cross-border healthcare starts from a simple premise: the country where a prescription is written and the country where the patient collects the medicine need not be the same one. Where a medicine is authorised for marketing in Malta, a prescription issued in another Member State for a named patient can be dispensed here, subject to the national rules that govern dispensing.

The same directive allows recognition of an individual prescription to be limited in two situations: where the limitation is restricted to what is necessary and proportionate to safeguard human health, and where there are legitimate and justified doubts about the authenticity, content or comprehensibility of that individual prescription. Refusing a document purely because it was written abroad is not one of them.

Commission Implementing Directive 2012/52/EU adds the practical half of the arrangement. Its Annex lists the elements a prescription should carry so that a health professional in another country can read it and check it. The purpose of the list is not paperwork for its own sake: a pharmacist in Valletta or Sliema does not know the prescription forms used in twenty-six other countries and needs enough on the page to identify the patient, the prescriber and the medicine.

Recognition means the absence of a refusal based on the country of issue. It does not mean that Maltese dispensing rules stop applying, and it does not mean the medicine will be funded by the government. Those are two different questions, each governed by its own rules, and patients routinely merge them into one.

Which details the prescription must carry

The Annex sets out a list of elements that is expressly non-exhaustive. It is grouped under four headings, and it is worth knowing them, because a missing field is the commonest point at which dispensing stalls.

Patient details: surname and first name, written out in full rather than initialled, and date of birth.

Authentication of the prescription: the date of issue.

Prescriber details: surname and first name written out in full, professional qualification, direct contact details including an e-mail address and a telephone or fax number with the international dialling code, the work address including the Member State concerned, and a signature, written or digital depending on the medium on which the prescription is issued.

Details of the prescribed product: the common name, meaning the international non-proprietary name of the active substance; the brand name only where the product is a biological medicinal product, or where the prescriber considers it medically necessary, in which case brief reasons are given; the pharmaceutical form, such as tablet or solution; the quantity; the strength; and the dosage regimen. Keep the whole document rather than handing over a fragment or a photograph with the edge cut off.

Why the medicine is named by its active substance and not by the brand on the box

The same active substance reaches the market under different brand names in different Member States. The box a patient knows from home often does not exist in a Maltese pharmacy, while the substance itself is entirely routine and stocked. That is why the Annex makes the common name the rule and the brand name the exception.

There are two exceptions. The first is a biological medicinal product, where preparations are not simply interchangeable and it matters which one was prescribed. The second is where the prescriber judges the brand name to be medically necessary, and then short reasons belong on the prescription itself.

For a patient this has a very practical consequence. At the counter, do not ask for the name on your box; give the name of the active substance, the strength and the pharmaceutical form. Which products containing that substance are authorised in Malta is a matter for the Medicines Authority, and the substance name is always printed in the patient information leaflet inside every pack.

If you take a medicine from one of the common groups, the substance name is also on our information pages: /medicines/eltroxin/ for levothyroxine, /medicines/simvastatin/ for simvastatin or /medicines/ventolin/ for salbutamol. Those pages explain what the medicine is used for and what to watch out for; they do not replace the leaflet in the pack or an assessment by a doctor.

What the pharmacist checks, and why a pharmacist can still say no

Recognition of a prescription from another Member State does not take the professional judgement away from the pharmacist. Where there are justified doubts about the authenticity of the document, about its content or legibility, or about whether it was issued for the person standing at the counter, dispensing can be declined. That is not an oddity and it is not a sign that something is wrong with the paperwork; it is part of the professional responsibility a pharmacist carries, and the profession in Malta is regulated by the Pharmacy Council.

It is therefore sensible to carry an identity document showing the same name and date of birth as the prescription, so an identity card or a passport. A mismatch of names, after a change of surname for example, stalls more supplies than the content of the prescription does.

There is a second, more mundane reason for a refusal: the product may simply not be stocked, or the strength you need may not be the one authorised locally. Ringing ahead saves a walk, and a pharmacist who has seen the document once is usually willing to say what can be ordered.

It would be untrue to promise that every counter in Malta handles documents from other Member States every day. Some take them as routine, others ask more questions. If one pharmacy declines, ask what specifically stopped the supply, because the answer decides whether you need a different pharmacy or a different prescription.

Which medicines fall outside this route

The cross-border route does not cover everything. Article 11(6) of Directive 2011/24/EU excludes medicinal products subject to special medical prescription, which in practice means narcotic and psychotropic substances. Benzodiazepines, Z-drug hypnotics, opioid painkillers, stimulants used in attention disorders and gabapentinoids belong to this group, and no document of this kind will be dispensed for them.

This is a legal boundary rather than a matter of our preference, and it is why we do not prescribe those substances at all. If your treatment includes one of them, it has to be handled by a prescriber in Malta.

Two further groups are outside what an assessment on paper can responsibly cover. An antibiotic for a new infection needs an examination, because deciding whether an antibiotic is needed at all, and which one, depends on findings that cannot be described in a form. Anything that amounts to a first diagnosis is in the same position: a questionnaire can review treatment that is already established, not open a new clinical question.

A recognised prescription is not the same as government funding

Malta funds medicines through the Government Formulary List and supplies them through the POYC scheme, under which entitled patients collect their government-funded medicines from a community pharmacy of their choice. Whether a particular medicine is on that list, and whether a particular patient is entitled to it, is decided by the Ministry for Health under the rules of the scheme.

A prescription issued in another Member State, including one issued by us, is a private document and is not part of that scheme. You pay for the medicine yourself at the pharmacy. We arrange no reimbursement and we cannot put a medicine on any funding list.

If you are entitled under a government scheme and your medicine is on the list, the cheapest route is almost always the scheme itself, through your POYC pharmacy or your health centre. The cross-border route is useful where the scheme does not reach: a visitor without an entitlement here, a medicine that is not on the list, or a gap in a long-term treatment that you need to close privately.

What we issue, and what we do not do

How we work: you fill in a medical questionnaire and a doctor reads your answers and the documents you attach. There is no video consultation, no telephone consultation and no live chat. If the doctor decides a prescription is appropriate, you receive a PDF prescription by e-mail, drawn up to the Annex of Commission Implementing Directive 2012/52/EU. You print it or open it on your phone and bring it to a pharmacy in Malta together with photo identification.

Two things about the document are worth stating plainly. The doctor is registered in Poland and is not registered with the Medical Council of Malta, which keeps the mandatory register of doctors here. The prescription is therefore a private cross-border document: it is not entered in any Maltese state health record, it does not appear in myHealth, and it is not part of the Government Formulary List or the POYC scheme. You pay for the medicine yourself at the pharmacy.

We do not prescribe benzodiazepines, Z-drug hypnotics, opioids, stimulants or gabapentinoids. Narcotic and psychotropic substances are excluded from cross-border prescriptions under Article 11(6) of Directive 2011/24/EU, and a first diagnosis, an antibiotic for a new infection or anything that needs an examination belongs with a doctor who can examine you in Malta.

A repeat prescription request costs 24,90 €, contraception 24,90 € and weight loss treatment 29,90 €; priority handling is an additional 9,90 €. The fee covers the medical assessment of your answers by a doctor, not the issuing of a document. If the doctor declines on medical or legal grounds, the fee is refunded. If the doctor asks you for documentation, you have at least 7 days to provide it and we will remind you before the deadline; if the consultation cannot be completed, we refund the full amount.